The Diabetes Annuals serve as a guide to the interpretation of new data which have appeared in the literature. Each Annual concentrates on recent advances only, and so a particular topic is therefore not necessarily covered every year, depending on the progress and publications within a given area over a given year. Thus, the Diabetes Annuals provide up-to-date accounts of recent developments in diabetes to all those with an interest in the subject. Much new information has been published in the period since Volume 4 appeared, with progress on many fronts. Volume 5 again guides the reader through the most recent literature, with a lot of familiar topics and names reappearing. There is a special chapter given over to aldose reductase inhibitors, resulting from the interest generated in this area.
The Diabetes Annuals serve as a guide to the interpretation of new data which have appeared in the literature. Each Annual concentrates on recent advances only, and so a particular topic is therefore not necessarily covered every year, depending on the progress and publications within a given area over a given year. Thus, the Diabetes Annuals provide up-to-date accounts of recent developments in diabetes to all those with an interest in the subject. Much new information has been published in the period since Volume 4 appeared, with progress on many fronts. Volume 5 again guides the reader through the most recent literature, with a lot of familiar topics and names reappearing. There is a special chapter given over to aldose reductase inhibitors, resulting from the interest generated in this area.
Reihe
Sprache
Verlagsort
Verlagsgruppe
Elsevier Science & Technology
Zielgruppe
Für höhere Schule und Studium
Für Beruf und Forschung
Maße
Gewicht
ISBN-13
978-0-444-81207-0 (9780444812070)
Copyright in bibliographic data is held by Nielsen Book Services Limited or its licensors: all rights reserved.
Schweitzer Klassifikation
1. Epidemiology of diabetes mellitus (P. Zimmet et al). 2. Immunology of diabetes (Type I diabetes) - 1989 (A.G. Ziegler and G.S. Eisenbarth). 3. Non-insulin-dependent diabetes (NIDDM): Speculations on etiology (G.M. Reaven). 4. Diabetes in tropical developing countries (C.S. Yajnik). 5. Current trends in dietary management of diabetes (D.L. Boctor and D.J.A. Jenkins). 6. Sulphonylurea therapy (L.P. Krall). 7. New oral hypoglycaemic drugs (H.S.A. Sherratt and K.G.M.M. Alberti). 8. Insulin injection therapy (P.D. Home and J.C. Thow). 9. Other routes of insulin therapy (P. Micossi and G. Pozza). 10. Diabetes and exercise: Clinical implications (B. Zinman). 11. Education: New definitions, new directions (S.M. Dunn and J.R. Turtle). 12. Computers and patient management systems in diabetes (R.G. Mazze). 13. Diabetes in the young (Z. Laron and M. Karp). 14. Islet transplantation (P.E. Lacy). 15. Recent advances in enzyme-based electrochemical glucose sensors (M.F. Cardosi and A.P.F. Turner). 16. Diabetic retinopathy (E.M. Kohner and M. Porta). 17. New insights into the genesis of diabetic kidney disease in insulin-dependent diabetic patients (G. Viberti). 18. Diabetic neuropathy (J.D. Ward). 19. Aldose reductase inhibitors (N. Hotta and N. Sakamoto). 20. Hypertension in diabetes (P.L. Drury). 21. Obesity and diabetes (P. Bjorntorp). 22. Hyperglyceamic emergencies and surgery: An update (S. Marshall and K.G.M.M. Alberti). 23. Plasma lipids and lipoproteins in diabetes mellitus (M.F. Laker and P.H. Winocour). 24. Microangiopathy (J.A. Colwell). 25. Insulin secretion in vitro (G.W.G. Sharp and C.R. Bliss). 26. The insulin receptor: Its role in insulin action and in the pathogenesis of insulin resistance (H. Haering and B. Obermaier-Kusser). 27. Insulin action: Mechanisms involved in the effects of insulin on gene expression and protein synthesis (J.M. Tavare et al). 28. Insulin action in vivo (S.N. Davis et al). 29. Glucose transport in muscle and fat (J.E. Foley et al). 30. Growth hormone, insulin-like growth factors and diabetes (A. Flyvbjerg and H. Orskov). Subject index.
